Cargando…
Neuropeptide Y protects kidney against cisplatin-induced nephrotoxicity by regulating p53-dependent apoptosis pathway
Cisplatin is a platinum-based chemotherapeutic drug for treating various types of cancers. However, the use of cisplatin is limited by its negative effect on normal tissues, particularly nephrotoxicity. Various mechanisms such as DNA adduct formation, mitochondrial dysfunction, oxidative stress, and...
Autores principales: | Kim, Namoh, Min, Woo-Kie, Park, Min Hee, Lee, Jong Kil, Jin, Hee Kyung, Bae, Jae-sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070709/ https://www.ncbi.nlm.nih.gov/pubmed/26728272 http://dx.doi.org/10.5483/BMBRep.2016.49.5.231 |
Ejemplares similares
-
Neuropeptide Y-based recombinant peptides ameliorate bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization
por: Park, Min Hee, et al.
Publicado: (2017) -
Neuropeptide Y improves cisplatin-induced bone marrow dysfunction without blocking chemotherapeutic efficacy in a cancer mouse model
por: Park, Min Hee, et al.
Publicado: (2017) -
Role of neuropeptide Y in the bone marrow hematopoietic stem cell microenvironment
por: Park, Min Hee, et al.
Publicado: (2015) -
AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells
por: Im, Jin Young, et al.
Publicado: (2014) -
IL-10 Mediates Rosiglitazone-Induced Kidney Protection in Cisplatin Nephrotoxicity
por: Kim, Myung-Gyu, et al.
Publicado: (2010)